Facebook pixel

tagged with @PSugarbaker

War against cancer

Interview with Dr Sugarbaker, the renowned surgical oncologist on what the future holds for treating the disease.

Dr Paul Sugarbaker

Dr Paul Sugarbaker

Currently, Dr Sugarbaker is the Director for the Program in Peritoneal Surface Oncology. His interests are in gastrointestinal cancer, gynecologic malignancy and mesothelioma.

read more
CRS and HIPEC sounds complicated, what is it?

CRS and HIPEC sounds complicated, what is it?

Cytoreductive surgery (CRS) for pseudomyxoma peritonei (PMP) is a complex operation with the aim of removing all visible tumours, affected tissue and entire organs. The NICE guidelines recommends the Sugarbaker technique and defines the operation as radical.

read more
PSOGI 2018

PSOGI 2018

Pseudomyxoma Survivor representatives once again attended the bi-annual Peritoneal Surface Oncology Group International (PSOGI) conference, this time it was in Paris. The PSOGI aims to “improve the treatment and survival of peritoneal cancer patients by educating patients, by training physicians, by organizing meetings and by performing basic and clinical scientific research into peritoneal cancer and the different treatment modalities”.

read more
Gearing up for PSOGI 2018

Gearing up for PSOGI 2018

The PERITONEAL SURFACE ONCOLOGY GROUP INTERNATIONAL conference, now in its 11th year, is almost upon us. I can't quite believe it's been two years since we attended the one in Washington DC! PSOGI is a non-profit organisation which aims to promote research, education,...

read more

PMP Patients’ Meeting – Dr Paul Sugarbaker

Pseudomyxoma Survivor is proud to have sponsored the recent PMP Patients’ Meeting which was held in Basingstoke in May 2013. The first meeting of its kind in the UK, attendees heard sessions from Dr Paul Sugarbaker and patient advocates Amani Albedah, Dave Mason and Dawn Green as well as attending breakout sessions which covered a range of topics.

read more